MedTrace Logo

The Efficacy of Platelets Rich Plasma for Ovarian Rejuvenation

NCT03946813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-05-06

No results posted yet for this study

Summary

In recent years, an increased approach has appeared in the use of autologous blood products to assist tissue and organ healing. Application of platelet rich plasma (PRP) has emerged as a potential solution for infertile women with poor ovarian reserve in reproductive specialty.

Conditions

  • Infertility, Female

Interventions

OTHER

Autologous PRP preparation

For each patient, autologous PRP preparation havs to be injected to both ovaries and ultrasound (US) guide

Sponsors & Collaborators

  • High Institute for Infertility Diagnosis and Assisted Reproductive Technologies

    collaborator UNKNOWN

  • Al-Kindy College of Medicine

    lead OTHER

Principal Investigators

  • Thuraya H Abdulla, Professor · Arab Board for Medical Specializations

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-20
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03946813 on ClinicalTrials.gov